Table 3.
Frequency of abnormal diabetes screening tests at START and END by diet group*
| Diagnosis | VLC (n = 16) | HC-Starch (n = 13) | HC-Sugar (n = 12) | |||
|---|---|---|---|---|---|---|
| START | END | START | END | START | END | |
| Abnormal HbA1c | ||||||
| ≥5.7% | 0 | 0 | 0 | 0 | 0 | 0 |
| ≥39 mmol/mol | ||||||
| Abnormal fasting glucose | ||||||
| ≥100 mg/dL | 0 | 0 | 0 | 1 | 0 | 4 |
| ≥5.6 mmol/L | ||||||
| Abnormal glucose tolerance (2-h glucose) | ||||||
| ≥140 mg/dL | 10 | 10 | 9 | 7 | 8 | 2 |
| ≥7.8 mmol/L | ||||||
*
Frequency of participants presenting with abnormal diabetes screening tests at START (when all were habituated to a VLC prior to randomization) and END (during week 10 of test diet period).